Merck resubmits NDA for ezetimibe, atorvastatin
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 03 Jan, 2013
Singapore: US FDA has acknowledged the resubmission of a New Drug Application (NDA) for ezetimibe and atorvastatin table...Read more
Eli Lilly pipeline will counter patent cliff in 2014
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2013
Singapore: Eli Lilly and Company has outlined its strategies to face patent cliff expected in 2014. In a statement to in...Read more
BioPharma Asia: Is Asia ready to boost global drug pipeline?
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 17 Mar, 2014
Singapore: Asia share of global GDP, measured in purchasing power, has increased from 26.8 percent in 2001 to 33.8 perce...Read more
Novo Nordisk obesity drug trial confirms weight loss
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2013
Singapore: Novo Nordisk's 56-week double-blind phase IIIa clinical trial with liraglutide has shown that it has the pote...Read more
New TB cocktail drug holds great promise
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2012
Singapore: A novel anti-TB drug has generated encouraging results in a recent Phase II trial funded by the non-profit TB...Read more
Singapore univ prepares for trial of glaucoma drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2013
Singapore: For glaucoma patients, taking daily medication will soon become a thing of the past. With Nanyang Technologic...Read more
BioDuro opens discovery lab in Shanghai
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ab...Read more
FDA approves ZALTRAP for colorectal cancer
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 06 Aug, 2012
Singapore: Sanofi and Regeneron Pharmaceuticals have received US Food and Drug Administration (FDA) approval for ZALTRAP...Read more
Report on strategies to manage patent protection loss
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 06 Jul, 2012
Singapore: Exclusivity is everything in the pharmaceutical brand business. Without it, power over pricing disappears and...Read more
Eisai cancer drug gets orphan drug designation from Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
Singapore: Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multi...Read more
QRx Pharma gets FDA inputs on Moxduo
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2013
Singapore: Australia-based QRxPharma is proceeding with US FDA to discuss the company's Moxduo new drug application (NDA...Read more
Daiichi Sankyo enrolls patients for edoxaban trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Oct, 2012
Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...Read more
Daiichi, Amplimmune join hands for protein R&D
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2013
Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...Read more
Sankyo halts phase III trial of cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...Read more
Women are on greater risk for Alzheimer's disease: Report
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 17 Apr, 2014
Singapore: Carrying a copy of a gene variant called ApoE4 confers a substantially greater risk for Alzheimer's disease o...Read more
Boehringer Ingelheim´s Volasertib gets orphan drug designation in EU, US
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 17 Apr, 2014
Singapore: US Food and Drug Administration (FDA) and the European Commission have granted orphan drug designation to Boe...Read more
Money churning drugs of 2014: Report
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2014
Singapore: Gilead's drug Sovaldi for hepatitis C virus, GlaxoSmithKline/Theravance's Anoro Ellipta for Chronic Obstructi...Read more
Johnson & Johnson acquires Aragon Pharma
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2013
Singapore: Johnson & Johnson has acquired Aragon Pharmaceuticals, a privately-held pharmaceutical discovery and deve...Read more